Making The Leap From EU MDD To MDR Clinical Evidence (Part 1): Practical Advice
Executive Summary
Clinical evidence requirements are among the biggest challenges for manufacturers meeting the requirements of the EU’s new Medical Device Regulation. Maetrics’ Amie Smirthwaite explains how manufacturers should transition from the one to the other in part one of a three-part interview series with Medtech Insight.
You may also be interested in...
Making The Leap From EU MDD To MDR Clinical Evidence (Part 2): Differences In Expectations
Maetrics’ Amie Smirthwaite explains the fundamental differences in clinical evidence expectations under the MDR compared with the MDD in part two of a three-part interview.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.